New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?

Katharina Kranzer; Barbara Kalsdorf; Jan Heyckendorf; Sönke Andres; Matthias Merker; Sabine Hofmann-Thiel; Guido V Bloemberg; Harald Hoffmann; Stefan Niemann; Christoph Lange; Florian P Maurer

doi:10.1164/rccm.201902-0260LE

New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?

Am J Respir Crit Care Med. 2019 Aug 15;200(4):514-515. doi: 10.1164/rccm.201902-0260LE.

Authors

Katharina Kranzer^{1

2}, Barbara Kalsdorf^{1

3

4}, Jan Heyckendorf^{1

3

4}, Sönke Andres^{1

5}, Matthias Merker^{1

3}, Sabine Hofmann-Thiel^{6

7}, Guido V Bloemberg⁸, Harald Hoffmann^{6

7}, Stefan Niemann^{1

3}, Christoph Lange^{1

3

4

9}, Florian P Maurer^{1

10

11}

Affiliations

¹ 1Research Center BorstelBorstel, Germany.
² 2London School of Hygiene and Tropical MedicineLondon, United Kingdom.
³ 3German Center for Infection Research-DZIFBorstel, Germany.
⁴ 4University of LübeckLübeck, Germany.
⁵ 9National and WHO Supranational Reference Laboratory for MycobacteriaBorstel, Germany.
⁶ 5SYNLAB GautingGauting, Germany.
⁷ 6WHO Supranational Reference Laboratory for TuberculosisGauting, Germany.
⁸ 7University of ZürichZürich, Switzerland.
⁹ 8Karolinska InstituteStockholm, Sweden.
¹⁰ 10University of HamburgHamburg, Germanyand.
¹¹ 11National and WHO Supranational Reference Laboratory for Mycobacteria Borstel, Germany.

PMID: 31026398
DOI: 10.1164/rccm.201902-0260LE

No abstract available

Publication types

Letter

MeSH terms

Adult
Antitubercular Agents / therapeutic use*
Diarylquinolines / therapeutic use*
Extensively Drug-Resistant Tuberculosis / drug therapy
Female
Humans
Male
Practice Guidelines as Topic
Tuberculosis, Multidrug-Resistant / drug therapy*
World Health Organization

Substances

Antitubercular Agents
Diarylquinolines
bedaquiline